May 20, 2021

M&A Sector Spotlight: US Healthcare Opportunities

Webinar On-Demand
In partnership with Mergermarket

M&A activity in Healthcare is on the move in 2021 and is proving to hold its course as we make our way through Q2.  With many new prospects on the horizon, we invite you to join us as we kick off a series of sector spotlights with our panel discussion "US Healthcare Opportunities." 

In this on-demand webinar presented with Mergermarket, industry experts will discuss current market trends and examine topics expected to dominate activity over the next few years, including:

  • What’s next for telehealth, remote pt monitoring, valuations and M&A
  • Deciding exits: SPACs vs IPO/direct listings, vs recaps
  • Pharma and the rush to gene therapies, genetic markers and diagnostics
  • CROs, CDMOs and the rush to scale

PANELISTS

Mark Francis

Managing Director, Head of Healthcare, Houlihan Lokey

Michael B. Kennedy II

Regional Vice President, Datasite

Newton Juhng

Managing Director, Capital One

Dane Hamilton

Healthcare Editor, Mergermarket & Dealreporter (moderator)

  • Americas Deal Drivers FY2020

    What impact has the pandemic had on M&A in the Americas? Download this comprehensive review of last year's activity to learn more.

Note: the above link will take you to the marketing hub on Mergermarket.com to access the event.

You may also like:

The US M&A Landscape in a Shifting Policy Environment

Join Datasite, in partnership with The FT, during this live webinar as this esteemed panel of industry experts analyze the US dealmaking outlook amid new macroeconomic challenges.

M&A Sector Spotlight: US Industrials Opportunities

Industrial and chemical companies may not gather the same headlines as their technology or healthcare siblings, but they remain at the heart of the US M&A market, accounting for 15% of the deals so far this year. Join us for the final installment of our sector spotlight series, "US Industrials Opportunities".

Corporate Development Outlook: The Enterprise Edition

What's on the mind of corporate dealmakers from some of the world's largest organizations? Join us for the third installment of our quarterly corporate development roundtable series.